Sigba, Juliana R.
HRN: 11-25-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/29/2023
09/04/2023
IV
2.25mg
Q8hrs
CAP-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose